CAS Investment Management is a Promotion Investment Company .
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
CAS Investment Management Co., Ltd. (abbreviated as CASI)&s; s controlling shareholder is Chinese Academy of Sciences Holdings Co., Ltd. (CAS Holdings www.casholdings.com.cn ) and has State-owned Assets Supervision and Administration Commission of the State Council (SASAC http://www.sasac.gov.cn/n1180/index.html ) and an employee-owned company as shareholders. Its predecessor is the Chinese National Economic Council-CAS Scientific and Technological Promotion &a; Economic Development Foundation.With a mission of “providing capital support and value-added service to industrial leaders, and promoting them to be outstanding companies with international competitiveness”, CASI is dedicated to be a Chinese leading PE fund manager.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2015 | Yinyin Gufen | Angel Round | 485.4k |
6/2018 | Ickey | Series C | 0 |
3/2017 | TOPGEN | Post-IPO Equity | 3.6M |
7/2014 | Amoi Technology | Angel Round | 484k |
4/2021 | Zonsen Peplib Biotech | Series A | 0 |
2/2021 | Resproly | Series B | 0 |
7/2020 | TOPGEN | Series C | 0 |
8/2018 | Bitmain | Series B | 0 |
5/2011 | Qingdao Huarui Auto Parts Co., Ltd. | Series A | 2.3M |
10/2016 | Thunderobot | Venture Round | 3M |
9/2019 | Leyue Health | Series B | 0 |
11/2016 | X-Chip | Series B | 3M |
6/2015 | Epticore Microelectronics | Venture Round | 8.1M |
10/2016 | Thunderobot | Funding Round | 3M |
6/2022 | Hejian | Seed Round | 0 |
8/2017 | Cambricon Technologies | Series A | 100M |
4/2018 | Pingjia | Series B | 7.6M |
3/2020 | ExcelMab | Series A | 1.4M |
12/2021 | Wenext | Series B | 55M |
8/2018 | txzing.com | Series C | 4.4M |
4/2018 | Xpect Vision Technology | Series B | 6.3M |
12/2014 | fmart | Series A | 1.4M |
2/2017 | Raysdata | Series A | 1.5M |
5/2012 | Caslon | Series B | 13.9M |
12/2017 | Beijing GreenValley Technology | Series B | - |
7/2017 | Weizhi Wang | Series B | 2.9M |
6/2022 | Hejian | Seed Round | 0 |
12/2021 | Wenext | Series B | 0 |
4/2021 | Zonsen Peplib Biotech | Series A | 0 |
2/2021 | Resproly | Series B | 0 |
7/2020 | TOPGEN | Series C | 0 |
3/2020 | ExcelMab | Series A | 0 |
9/2019 | Leyue Health | Series B | 0 |
8/2018 | txzing.com | Series C | 0 |
8/2018 | Bitmain | Series B | 0 |
6/2018 | Ickey | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|